Cargando…

Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia

BACKGROUND: Vestibular paroxysmia (VP) is a rare episodic peripheral vestibular disorder. This study was conducted to compare the efficacy and acceptability of carbamazepine (CBZ) plus betahistine mesilate tablets (BMT) (CBZ+BMT) and oxcarbazepine (OXC) plus BMT (OXC+BMT) in treating VP, and investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Hui, Xiang, Wenping, Yu, Yichuan, Liu, Guorong, Chong, Yi, Zhou, Jiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905823/ https://www.ncbi.nlm.nih.gov/pubmed/29695895 http://dx.doi.org/10.2147/DDDT.S158888

Ejemplares similares

A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
por: Bayer, Otmar, et al.
Publicado: (2017)

Vestibular paroxysmia: Diagnostic criteria
por: Strupp, Michael, et al.
Publicado: (2017)

Vestibular paroxysmia in vestibular neuritis: A case report
por: Ori, Michele, et al.
Publicado: (2018)

Hyperventilation-Triggered Vertigo and Nystagmus in Vestibular Paroxysmia
por: Lee, Suk-Min, et al.
Publicado: (2020)

Tinnitus, Oscillopsia, and Hyperventilation-Induced Nystagmus: Vestibular Paroxysmia
por: Ward, Bryan K, et al.
Publicado: (2016)

Erratum: Hyperventilation-Triggered Vertigo and Nystagmus in Vestibular Paroxysmia
por: Lee, Suk-Min, et al.
Publicado: (2021)

Periodic Tinnitus and Direction-Changing Nystagmus in Vestibular Paroxysmia
por: Kim, Chang-Hee, et al.
Publicado: (2021)

Vestibular paroxysmia: clinical characteristics and long-term course
por: Steinmetz, Karoline, et al.
Publicado: (2022)

Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy
por: Berghuis, Bianca, et al.
Publicado: (2021)

Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome
por: Brandt, Thomas, et al.
Publicado: (2016)

Vestibular paroxysmia: Long-term clinical outcome after treatment
por: Chen, Chih-Chung, et al.
Publicado: (2022)

Betahistine in the treatment of tinnitus in patients with vestibular disorders
por: Ganança, Maurício Malavasi, et al.
Publicado: (2015)

Spectrophotometric estimation of betahistine hydrochloride in tablet formulations
por: Kumar, Amit, et al.
Publicado: (2010)

Vestibular paroxysmia associated with congenital vascular malformation: A case report
por: Liu, Fei, et al.
Publicado: (2023)

EHMTI-0355. Comparison of carbamazepine and oxcarbazepine tolerability in patients with trigeminal neuralgia
por: Cregg, R, et al.
Publicado: (2014)

7-Tesla MRI demonstrates absence of structural lesions in patients with vestibular paroxysmia
por: Rommer, Paulus S., et al.
Publicado: (2015)

Vestibular paroxysmia caused by contralateral tortuous vertebral artery: A case report
por: Choi, Jin Woo, et al.
Publicado: (2021)

The Narrowed Internal Auditory Canal: A Distinct Etiology of Pediatric Vestibular Paroxysmia
por: Idriss, Samar A., et al.
Publicado: (2022)

Application of ABR in pathogenic neurovascular compression of the 8th cranial nerve in vestibular paroxysmia
por: Sun, Huiying, et al.
Publicado: (2022)

Typewriter tinnitus with time-locked vestibular paroxysmia in a patient with cerebellopontine angle meningioma
por: Zhang, Yuzhong, et al.
Publicado: (2023)

Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital
por: Lee, Jung Eun, et al.
Publicado: (2020)

Effects of Betahistine on the Development of Vestibular Compensation after Unilateral Labyrinthectomy in Rats
por: Fukuda, Junya, et al.
Publicado: (2021)

A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
por: Berghuis, Bianca, et al.
Publicado: (2019)

Vestibular paroxysmia entails vestibular nerve function, microstructure and endolymphatic space changes linked to root-entry zone neurovascular compression
por: Kierig, Emilie, et al.
Publicado: (2022)

Betahistine Treatment in a Cat Model of Vestibular Pathology: Pharmacokinetic and Pharmacodynamic Approaches
por: Tighilet, Brahim, et al.
Publicado: (2018)

Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain
por: Di Stefano, Giulia, et al.
Publicado: (2014)

Successive occurrence of vertebrobasilar dolichectasia induced trigeminal neuralgia, vestibular paroxysmia and hemifacial spasm: A case report
por: Han, Jingzhe, et al.
Publicado: (2018)

Effects of oxcarbazepine versus carbamazepine on tinnitus: A randomized double-blind placebo-controlled clinical trial
por: Gerami, Hooshang, et al.
Publicado: (2012)

Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study
por: Băjenaru, Ovidiu, et al.
Publicado: (2014)

Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study
por: Parfenov, Vladimir A., et al.
Publicado: (2017)

Evaluation of Factors Impacting the Efficacy of Single or Combination Therapies of Valproic Acid, Carbamazepine, and Oxcarbazepine: A Longitudinal Observation Study
por: Peng, Qilin, et al.
Publicado: (2021)

Betahistine in the treatment of Ménière’s disease
por: Lacour, Michel, et al.
Publicado: (2007)

Development and Evaluation of Sustained Release Tablet of Betahistine Hydrochloride Using Ion Exchange Resin Tulsion T344
por: Wagh, Vijay D., et al.
Publicado: (2012)

Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022)

Cardiac arrest caused by nafamostat mesilate
por: Kim, Hyo Shik, et al.
Publicado: (2016)

Camostat mesilate therapy for COVID-19
por: Uno, Yoshiharu
Publicado: (2020)

Formulation and development of paediatric orally disintegrating carbamazepine tablets
por: Canadell-Heredia, R, et al.
Publicado: (2022)

Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo
por: Morozova, Svetlana Vyacheslavovna, et al.
Publicado: (2015)

Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)
por: Besi, E., et al.
Publicado: (2015)

Appraisal of the greenness profile of a chromatographic method for the simultaneous estimation of carbamazepine and oxcarbazepine, along with two potential impurities and three formulation excipients
por: Abdelwahab, Nada S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eeh2abroh6qfd01sc4enc4ioi4